当前位置: X-MOL 学术Aliment. Pharm. Ther. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Randomised clinical trial: the safety and tolerability of fluticasone propionate orally disintegrating tablets versus placebo for eosinophilic oesophagitis.
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2020-03-09 , DOI: 10.1111/apt.15670
Ikuo Hirano 1 , Ekaterina Safroneeva 2 , Marie C Roumet 3 , Gail M Comer 4 , Gina Eagle 4 , Alain Schoepfer 5 , Gary W Falk 6
Affiliation  

APT‐1011, a fluticasone propionate orally disintegrating tablet formulation, is under investigation for the treatment of eosinophilic oesophagitis (EoE).

中文翻译:

随机临床试验:丙酸氟替卡松口腔崩解片与安慰剂治疗嗜酸性食管炎的安全性和耐受性。

APT-1011是一种丙酸氟替卡松口服崩解片剂,目前正在研究用于治疗嗜酸性食管炎(EoE)。
更新日期:2020-03-09
down
wechat
bug